Often, medicinal discovery has focused on minute molecules, but peptidic alliances are progressively receiving momentum. This new methodology utilizes combining peptidic sequences with alternative biological methods to address challenging disease targets. By utilizing the specific characteristics of peptides – such as significant selectivity and